BioCentury
ARTICLE | Company News

Management tracks

June 4, 2015 2:25 AM UTC

Anti-infectives developer Paratek Pharmaceuticals Inc. (NASDAQ:PRTK) hired Yulii Bogatyrenko as SVP of business development and Randall Brenner as SVP of regulatory affairs and quality. Bogatyrenko was managing partner at Atem Capital, and Brenner was global head of regulatory affairs at Shire plc (LSE:SHP; NASDAQ:SHPG).

Cardiovascular company Armetheon Inc. (Menlo Park, Calif.) named Sanjay Kakkar CEO. Kakkar was founding chairman at Jai Medica Pvt. Ltd. (Bangalore, India). ...